新华都：2025年前三季度净利润约1.78亿元

Group 1 - Xinhua Du reported a revenue of approximately 2.446 billion yuan for the first three quarters of 2025, a year-on-year decrease of 11.84% [1] - The net profit attributable to shareholders was about 178 million yuan, reflecting a year-on-year decline of 6.51% [1] - Basic earnings per share were 0.26 yuan, down 3.7% compared to the previous year [1] Group 2 - As of the report date, Xinhua Du's market capitalization stood at 5 billion yuan [2] - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion US dollars this year [2] - There is a contrast in the biopharmaceutical secondary market's activity compared to the primary market, which is experiencing a fundraising slowdown [2]